Funds and ETFs Healius Limited

Equities

HLS

AU0000033359

Healthcare Facilities & Services

Market Closed - Australian S.E. 02:10:52 2024-04-24 am EDT 5-day change 1st Jan Change
1.25 AUD -1.19% Intraday chart for Healius Limited +3.73% -23.55%

ETFs positioned on Healius Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 773 M€ -.--% -
0.01% 10 M€ -3.35% -
0.01% 7 M€ +1.70% -
0.00% 34 M€ +2.35% -
Healius Limited is an Australia-based healthcare company. The Company operates through two segments: Pathology and Imaging. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment is a provider of imaging and scanning services at standalone imaging sites, hospitals, and medical centers. The Company has a network of pathology laboratories, collection centers, and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. The Company’s brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. The Company provides healthcare services that are accessible and efficient while supporting the coordination and continuity of quality patient care.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
13
Last Close Price
1.25 AUD
Average target price
1.364 AUD
Spread / Average Target
+9.13%
Consensus
  1. Stock Market
  2. Equities
  3. HLS Stock
  4. Funds and ETFs Healius Limited